Coreline Soft announced on the 21st that it is participating in a government-funded AI research project worth a total of 22 billion won, supported by the Ministry of Health and Welfare. The project aims to develop a multi-modal model and a healthcare service support platform to improve medical quality and operational efficiency. The government contribution amounts to approximately 213.75 billion won, with the participating institutions covering the remaining costs.
This initiative reflects the global trend of evolving from specialized (single-modal) AI models to versatile (multi-modal) models that integrate various data types. Led by Seoul Asan Medical Center, the project involves four companies — Coreline Soft, Naver Cloud, Public-AI, and Emocog — as well as eight hospitals, including Seoul National University Hospital and Bundang Cha Hospital, and two universities (KAIST and Ulsan University), making it the largest-scale medical AI R&D project in Korea.
Professor Yang Dong-hyun from Seoul Asan Medical Center, the project lead, stated, “Securely federating medical data across multiple institutions and analyzing diverse modalities such as imaging, documents, and speech will greatly enhance clinical efficiency and equity in future healthcare environments. This project is particularly significant in realizing a domestic, optimized medical large-language model (LLM).”
Coreline Soft will contribute by combining thoracic CT-based multi-disease analysis technology with generative AI to develop AI solutions tailored for specific medical specialties, including pediatrics, obstetrics, cancer, chronic diseases, and critical care. The aim is to improve clinical workflows, nursing, patient communication, research, and administrative efficiency.
CEO Kim Jin-gook expressed, “Participating in this government project allows our chest imaging analysis technology to be integrated into a multi-modal healthcare AI platform and to be validated in clinical settings, which is immensely meaningful. We will actively leverage our experience and expertise accumulated both domestically and internationally.”
Coreline Soft, last year, became Korea’s first medical AI company to obtain the ISO/IEC 42001 international standard certification for AI management systems. It also registered a U.S. patent for its ‘dual AI structure,’ designed to enhance AI reliability. Additionally, the company plans to incorporate its technologies and operational insights gained from global partnerships with Microsoft, Temple Health, and 3DR Labs into this project, aiming to establish itself as a comprehensive healthcare AI platform.